Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/MX6A stock hub

FRA/MX6A has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/MX6Ais not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.3B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/MX6A

In the news

Latest news · FRA/MX6A

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.2

P25 n/aP50 n/aP75 n/a

Trailing P/E17.2

P25 n/aP50 n/aP75 n/a

ROE7.4

P25 n/aP50 n/aP75 n/a

ROIC7.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/MX6A market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

HKD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Bermuda
Country code	DE
Employees	12,614
Employees Change	627%
Employees Change Percent	5.23
Enterprise value	EUR 2.4B
Exchange	Frankfurt Stock Exchange
Financial currency	HKD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 2.3B
Price	EUR 0.64
Price currency	EUR
Rev Per Employee	106,555.6x
Sic	2834
Symbol	fra/MX6A
Website	https://www.grandpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.81%
EV Earnings	17.98x
EV/EBIT	12.21x
EV/EBITDA	9.28x
EV/FCF	24.16x
EV/Sales	1.83x
FCF yield	4.32%
Forward P/E	13.24x
P/B ratio	1.24x
P/E ratio	17.21x
P/S ratio	1.74x
PE Ratio10 Y	9.62x
PE Ratio3 Y	13.06x
PE Ratio5 Y	10.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.38%
EBITDA Margin	18.8%
FCF margin	7.52%
Gross margin	55.2%
Gross Profit	EUR 741.9M
Gross Profit Growth	0.49%
Gross Profit Growth Q	1.05%
Gross Profit Growth3 Y	2.77%
Gross Profit Growth5 Y	0.66%
Net Income	EUR 135.8M
Net Income Growth	-49.73%
Net Income Growth Q	-92.11%
Net Income Growth3 Y	-19.83%
Net Income Growth5 Y	-12.35%
Pretax Margin	12.16%
Profit Margin	10.1%
Profit Per Employee	EUR 10,764
ROA	4.23
Roa5y	6.62
ROCE	8.9
ROE	7.38
Roe5y	14.07
ROIC	7.76
Roic5y	13.18

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-13.52%
Cagr3y	7.71%
Div CAGR3	31.27%
EPS Growth	-49.73
EPS Growth Q	-92.12
EPS Growth3 Y	-19.89
EPS Growth5 Y	-12.12
Revenue Growth	5.48x
Revenue Growth Q	10.33x
Revenue Growth3 Y	5.08x
Revenue Growth5 Y	3.51x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.47
Assets	EUR 3B
Cash	EUR 429.7M
Current Assets	EUR 899.5M
Current Liabilities	EUR 792.2M
Debt	EUR 517M
Debt EBITDA	EUR 2.01
Debt Equity	EUR 0.28
Debt FCF	EUR 5.12
Equity	EUR 1.9B
Interest Coverage	10.88
Liabilities	EUR 1.1B
Long Term Assets	EUR 2.1B
Long Term Liabilities	EUR 300.6M
Net Cash	EUR -87.3M
Net Cash By Market Cap	EUR -3.73
Net Debt EBITDA	EUR 0.35
Net Debt Equity	EUR 0.05
Net Debt FCF	EUR 0.86
Tangible Book Value	EUR 1.3B
Tangible Book Value Per Share	EUR 0.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.14
Inventory Turnover	3.86
Net Working Capital	EUR -10.2M
Quick ratio	0.93
Working Capital	EUR 108.4M
Working Capital Turnover	EUR 1.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	-3.4%
Dividend Growth Years	0%
Dividend per share	EUR 0.03
Dividend Years	5
Dividend Yield	4.62%
Ex Div Date	2025-04-14
Last Dividend	EUR 0.03
Payout Frequency	Annual
Payout Ratio	73.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-13.51%
200-day SMA	0.85
3Y total return	24.96%
50-day SMA	0.73
50-day SMA vs 200-day SMA	50under200
All Time High	1.07
All Time High Change	-40.19%
All Time High Date	2025-06-12
All Time Low	0.38
All Time Low Change	69.31%
All Time Low Date	2024-02-09
ATR	0.02
Ch YTD	-29.67
High	0.64
High52	1.07
High52 Date	2025-06-12
High52ch	-40.19%
Low	0.64
Low52	0.63
Low52 Date	2026-05-07
Low52ch	1.59%
Ma50ch	-11.89%
Price vs 200-day SMA	-24.49%
RSI	35.56
RSI Monthly	44.24
RSI Weekly	27.55
Sharpe ratio	-0.42x
Sortino ratio	-0.5
Total Return	4.62%
Tr YTD	-29.67
Tr1m	-17.42%
Tr1w	-0.78%
Tr3m	-22.42%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 193.3M
Operating Income Growth	-9.78
Operating Income Growth Q	-25.05
Operating Income Growth3 Y	-16.5
Operating Income Growth5 Y	-7.43
Operating margin	14.38

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,255,945,266%
Shares Insiders	55.39%
Shares Institutions	12.17%
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 101M
Average Volume	41.45x
Bv Per Share	0.53
CAPEX	EUR -79.5M
Ch1m	-17.42
Ch1w	-0.78
Ch1y	-13.51
Ch3m	-22.42
Ch3y	9.4
Ch6m	-29.67
Change	1.59%
Change From Open	0
Close	0.63
Days Gap	1.59
Depreciation Amortization	49,089,773
Earnings Date	2026-05-19
EBIT	EUR 193.3M
EBITDA	EUR 252.7M
EPS	EUR 0.04
F Score	5
FCF	EUR 101M
FCF EV Yield	4.14x
Financing CF	-104,122,017
Fiscal Year End	December
Founded	1,995
Goodwill	181,563,838.4
Graham Number	0.65623
Graham Upside	2.54
Income Tax	EUR 27.3M
Investing CF	-105,869,966
Is Primary Listing	0
Last Report Date	2025-12-31
Lynch Fair Value	EUR 0.19
Lynch Upside	-70.95
Ma150	0.82
Ma150ch	-21.5%
Ma20	0.67
Ma20ch	-5.02%
Net CF	-21,732,715
Next Earnings Date	2026-05-19
Open	0.64
P FCF Ratio	23.13
P OCF Ratio	12.95
Payment Date	2025-04-28
Position In Range	100
Ppne	522,372,981.7
Price Date	2026-05-08
Price EBITDA	EUR 9.25
Ptbv Ratio	1.77
Relative Volume	19.88x
Revenue	1,344,092,323x
Tax By Revenue	2.03x
Tax Rate	16.72%
Tr6m	-29.67%
Z Score	2.88

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/MX6A dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.6%

$0.03 annual per share

Payout ratio

+73.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+4.6%

Next ex-dividend date: 2025-04-14

Performance

FRA/MX6A stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/MX6A?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.2%

Share of float held by funds and institutions

Insider ownership

+55.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

FRA/MX6A momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

35.6

Neutral momentum band

Price vs 200-day MA

-24.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.42

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/MX6A

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/MX6A stock rating?

fra/MX6A is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/MX6A analysis?

The full report lives at /stocks/fra/MX6A/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/MX6A?

The latest report frames fra/MX6A around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/MX6A page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.